Alpha 2.0
Login Register
» Articles » PMID: 5649002

Body Height and Imipramine Side-effects

Overview
Journal Br Med J
Specialty General Medicine
Date 1968 May 18
PMID 5649002
Citations 1
Authors
A M Porter
Affiliations
Soon will be listed here.
Citing Articles

Depressive illness in a general practice. A demographic study and a controlled trial of imipramine.

Porter A Br Med J. 1970; 1(5699):773-8.

PMID: 4910188 PMC: 1699663. DOI: 10.1136/bmj.1.5699.773.

References
1.
MOODY J, TAIT A, Todrick A . Plasma levels of imipramine and desmethylimipramine during therapy. Br J Psychiatry. 1967; 113(495):183-93. DOI: 10.1192/bjp.113.495.183. View
2.
Hammer W, Sjoqvist F . Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds. Life Sci. 1967; 6(17):1895-903. DOI: 10.1016/0024-3205(67)90218-4. View
3.
Motulsky A . Drug reactions enzymes, and biochemical genetics. J Am Med Assoc. 1957; 165(7):835-7. DOI: 10.1001/jama.1957.72980250010016. View
4.
Evans D, DAVISON K, PRATT R . THE INFLUENCE OF ACETYLATOR PHENOTYPE ON THE EFFECTS OF TREATING DEPRESSION WITH PHENELZINE. Clin Pharmacol Ther. 1965; 6:430-5. DOI: 10.1002/cpt196564430. View
5.
Evans D . INDIVIDUAL VARIATIONS OF DRUG METABOLISM AS A FACTOR IN DRUG TOXICITY. Ann N Y Acad Sci. 1965; 123:178-87. DOI: 10.1111/j.1749-6632.1965.tb12255.x. View